COVID-19 in Patients with Inflammatory Bowel Disease: The Israeli Experience.
Lev LichtensteinBenjamin KoslowskyAmi Ben Ya'acovIrit Avni-BironBaruch OvadiaOfer Ben-BassatTimna NaftaliUri KopylovYael HabermanHagar Banai EranRami EliakimAdi Lahat-ZokAyal HirschEran ZittanNitsan MaharshakMatti WatermanEran IsraeliIdan GorenJacob E OllechHenit YanaiBella UngarBenjamin AvidanDana Ben HurBernardo MelamudOri SegolZippora ShalemIris DotanSelwyn H OdesShomron Ben-HorinYf'at SnirYael MilgromEfrat BroideEran GoldinShmuel DelgadoYulia RonNathaniel Aviv CohenEran MaozMaya ZborovskySafwat OdehNaim Abu FrehaEyal ShacharYehuda ChowersTal EngelHila Reiss-MintzArie SegalAdar ZingerAriella Bar-Gil ShitritPublished in: Vaccines (2022)
We did not witness aggravated COVID-19 outcomes in patients with IBD. Patients treated with biologics had a favorable outcome.